Ask the Doctors August 2007 Issue

Ask The Doctors: 08/07

This is a challenging question and the source of much media attention and controversy. The differentiation between "on-label" and "off-label" has do to with whether the U.S. Food and Drug Administration (FDA) determines that there is enough evidence of benefit and safety supporting a specific use of the product that this information should be on the package insert that comes with the drug or device. "Off label" uses for a stent could include treating bypass graft lesions or for lesions of a certain size not specified on the label. In general, "on-label" products have more data to support their use for those purposes.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.